• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙化动脉中骨桥蛋白、骨保护素及其他细胞外基质蛋白之间的关系

Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries.

作者信息

Kuzan Aleksandra, Chwiłkowska Agnieszka, Maksymowicz Krzysztof, Abramczyk Urszula, Gamian Andrzej

机构信息

Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Faculty of Medicine, Wrocław University of Science and Technology, Wybrzeże Stanisława Wyspiańskiego 27, 50-370 Wroclaw, Poland.

Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

出版信息

Biomedicines. 2024 Apr 11;12(4):847. doi: 10.3390/biomedicines12040847.

DOI:10.3390/biomedicines12040847
PMID:38672202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11048129/
Abstract

Osteopontin (OPN) and osteoprotegerin (OPG) are glycoproteins that participate in the regulation of tissue biomineralization. The aim of the project is to verify the hypothesis that the content of OPN and OPG in the aorta walls increases with the development of atherosclerosis and that these proteins are quantitatively related to the main proteins in the extracellular arteries matrix. Quantitative and qualitative analyses of the OPN and OPG content in 101 aorta sections have been conducted. Additionally, an enzyme-linked immunosorbent assay (ELISA) test has been performed to determine the collagen types I-IV and elastin content in the tissues. Correlations between the biochemical data and patients' age/sex, atherosclerosis stages, and calcification occurrences in the tissue have been established. We are the first to report correlations between OPN or OPG and various types of collagen and elastin content (OPG/type I collagen correlation: r = 0.37, = 0.004; OPG/type II collagen: r = 0.34, = 0.007; OPG/type III collagen: r = 0.39, = 0.002, OPG/type IV collagen: r = 0.27, = 0.03; OPG/elastin: r = 0.42, = 0.001; OPN/collagen type I: r = 0.34, = 0.007; OPN/collagen type II: r = 0.52, = 0.000; OPN/elastin: r = 0.61, = 0.001). OPN overexpression accompanies calcium deposit (CA) formation with the protein localized in the calcium deposit, whereas OPG is located outside the CA. Although OPN and OPG seem to play a similar function (inhibiting calcification), these glycoproteins have different tissue localizations and independent expression regulation. The independent expression regulation presumably depends on the factors responsible for stimulating the synthesis of collagens and elastin.

摘要

骨桥蛋白(OPN)和骨保护素(OPG)是参与组织生物矿化调节的糖蛋白。该项目的目的是验证以下假设:主动脉壁中OPN和OPG的含量会随着动脉粥样硬化的发展而增加,并且这些蛋白质与细胞外动脉基质中的主要蛋白质存在定量关系。已对101个主动脉切片中OPN和OPG的含量进行了定量和定性分析。此外,还进行了酶联免疫吸附测定(ELISA)试验,以确定组织中I-IV型胶原蛋白和弹性蛋白的含量。已建立了生化数据与患者年龄/性别、动脉粥样硬化阶段以及组织中钙化发生情况之间的相关性。我们首次报告了OPN或OPG与各种类型胶原蛋白和弹性蛋白含量之间的相关性(OPG/I型胶原蛋白相关性:r = 0.37,P = 0.004;OPG/II型胶原蛋白:r = 0.34,P = 0.007;OPG/III型胶原蛋白:r = 0.39,P = 0.002,OPG/IV型胶原蛋白:r = 0.27,P = 0.03;OPG/弹性蛋白:r = 0.42,P = 0.001;OPN/I型胶原蛋白:r = 0.34,P = 0.00 —— 此处原文有误,应为P = 0.007;OPN/II型胶原蛋白:r = 0.52,P = 0.000;OPN/弹性蛋白:r = 0.61,P = 0.001)。OPN的过表达伴随着钙沉积物(CA)的形成,该蛋白定位于钙沉积物中,而OPG位于CA之外。尽管OPN和OPG似乎发挥着相似的功能(抑制钙化),但这些糖蛋白具有不同的组织定位和独立的表达调控。这种独立的表达调控可能取决于负责刺激胶原蛋白和弹性蛋白合成的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/d287627a8859/biomedicines-12-00847-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/0ffa3c771b86/biomedicines-12-00847-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/6be7f3678375/biomedicines-12-00847-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/0a38346a8b78/biomedicines-12-00847-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/c6ca8591880d/biomedicines-12-00847-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/3c31e16d8805/biomedicines-12-00847-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/d287627a8859/biomedicines-12-00847-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/0ffa3c771b86/biomedicines-12-00847-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/6be7f3678375/biomedicines-12-00847-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/0a38346a8b78/biomedicines-12-00847-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/c6ca8591880d/biomedicines-12-00847-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/3c31e16d8805/biomedicines-12-00847-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae4a/11048129/d287627a8859/biomedicines-12-00847-g006.jpg

相似文献

1
Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries.钙化动脉中骨桥蛋白、骨保护素及其他细胞外基质蛋白之间的关系
Biomedicines. 2024 Apr 11;12(4):847. doi: 10.3390/biomedicines12040847.
2
Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?骨桥蛋白和护骨素在动脉粥样硬化斑块中的作用——它们是斑块易损性的重要标志物吗?
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):793-801. doi: 10.47162/RJME.61.3.17.
3
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.血清血管钙化抑制剂水平与颈动脉斑块易损性之间的关系。
J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.
4
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.血清骨保护素和骨桥蛋白水平与动脉僵硬度以及冠状动脉疾病的存在和严重程度相关。
Int J Cardiol. 2013 Sep 1;167(5):1924-8. doi: 10.1016/j.ijcard.2012.05.001. Epub 2012 May 27.
5
Bone metabolism regulators and arterial stiffness in postmenopausal women.绝经后妇女的骨代谢调节剂与动脉僵硬。
Maturitas. 2013 Oct;76(2):146-50. doi: 10.1016/j.maturitas.2013.07.001. Epub 2013 Aug 1.
6
Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.2 型糖尿病患者骨基质糖蛋白模式受损与增加的心血管代谢风险特征相关。
J Endocrinol Invest. 2019 May;42(5):513-520. doi: 10.1007/s40618-018-0941-x. Epub 2018 Aug 21.
7
Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma.碱性磷酸酶、骨桥蛋白、核因子κB受体活化因子配体及骨保护素在钙化的人颈动脉粥样斑块中的分布
Protein J. 2015 Oct;34(5):315-28. doi: 10.1007/s10930-015-9620-3.
8
Serum and tissue biomarkers in aortic stenosis.主动脉瓣狭窄中的血清和组织生物标志物。
Glob Cardiol Sci Pract. 2015 Nov 13;2015(4):49. doi: 10.5339/gcsp.2015.49. eCollection 2015.
9
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.阿那曲唑治疗的绝经后晚期乳腺癌患者血清骨保护素和骨桥蛋白水平
Endocr Relat Cancer. 2004 Dec;11(4):771-9. doi: 10.1677/erc.1.00775.
10
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis.骨保护素和骨桥蛋白在有症状的颈动脉粥样硬化中高浓度表达。
Stroke. 2004 Jul;35(7):1636-41. doi: 10.1161/01.STR.0000129790.00318.a3. Epub 2004 May 13.

引用本文的文献

1
Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients.预测终末期肾病患者严重冠状动脉钙化的列线图模型。
Ren Fail. 2024 Dec;46(2):2365393. doi: 10.1080/0886022X.2024.2365393. Epub 2024 Jun 14.

本文引用的文献

1
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.PCSK9 抑制剂对动脉粥样硬化斑块稳定性的影响:生化和诊断影像学方法的评估。
Molecules. 2023 Aug 7;28(15):5928. doi: 10.3390/molecules28155928.
2
Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.血清骨桥蛋白和护骨素水平与外周动脉疾病血管内再通后不良结局的关系。
Cardiovasc Diabetol. 2022 Sep 1;21(1):171. doi: 10.1186/s12933-022-01605-6.
3
The roles of osteoprotegerin in cancer, far beyond a bone player.
骨保护素在癌症中的作用,远不止是一个与骨骼相关的角色。
Cell Death Discov. 2022 May 6;8(1):252. doi: 10.1038/s41420-022-01042-0.
4
Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes.糖尿病患者微血管并发症中骨桥蛋白水平的决定因素
Int J Gen Med. 2022 Apr 27;15:4433-4440. doi: 10.2147/IJGM.S354220. eCollection 2022.
5
Extracellular Matrix in Aging Aorta.衰老主动脉中的细胞外基质
Front Cell Dev Biol. 2022 Feb 21;10:822561. doi: 10.3389/fcell.2022.822561. eCollection 2022.
6
Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction.急性心肌梗死患者血清骨保护素水平与冠状动脉疾病严重程度的关联
J Clin Med. 2021 Sep 23;10(19):4326. doi: 10.3390/jcm10194326.
7
Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology-A Pilot Study.糖基化和氧化应激对甲状腺腺体病理学的影响——一项初步研究。
Biomolecules. 2021 Apr 10;11(4):557. doi: 10.3390/biom11040557.
8
Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?骨桥蛋白和护骨素在动脉粥样硬化斑块中的作用——它们是斑块易损性的重要标志物吗?
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):793-801. doi: 10.47162/RJME.61.3.17.
9
The Leading Causes of Death in the US for 2020.2020年美国的主要死因。
JAMA. 2021 May 11;325(18):1829-1830. doi: 10.1001/jama.2021.5469.
10
Relationship between calcification, atherosclerosis and matrix proteins in the human aorta.人主动脉中的钙化、动脉粥样硬化与基质蛋白之间的关系。
Folia Histochem Cytobiol. 2021;59(1):8-21. doi: 10.5603/FHC.a2021.0002. Epub 2021 Feb 9.